#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Penile cancer Immune-mediated enterocolitis Myelodysplastic syndrome with excess blasts Demyelination Marginal zone lymphoma Palmoplantar pustulosis Plasma cell myeloma recurrent Bile acid synthesis disorder Autoimmune disorder Pituitary-dependent Cushing's syndrome Neuronal ceroid lipofuscinosis Neuroendocrine carcinoma metastatic Angelman's syndrome Crohn's disease Hypochromic anaemia More trials…

    Learn about Rare Diseases

    Familial haemophagocytic lymphohistiocytosis – Diagnostics Pemphigoid – Trials in Disease Haemolytic uraemic syndrome – Treatment Paroxysmal nocturnal haemoglobinuria – Diagnostics Wiskott-Aldrich syndrome Pleural mesothelioma malignant – Life with Disease Mucous membrane pemphigoid Arterial tortuosity syndrome – Diagnostics Netherton’s syndrome – Treatment Thrombotic thrombocytopenic purpura – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Chlorpromazine Hydrochloride Wve-006 Rineterkib Darolutamide RNMB2 MAGNESIUM CARBONATE HEAVY Vigabatrin Pp1493 Octreotide Hydrochloride Nitric Oxide Hypromellose Pehero Tovorafenib Mercaptamine [Al[18F]F]Fapi-74 Daxdilimab Cinnarizine Ipatasertib Lactose Monohydrate Gadoteridol More therapies…

    Learn about Your Condition

    Mantle cell lymphoma stage IV Dizziness Onychomycosis Paresis Laryngeal cancer stage II Pertussis Genital herpes Migraine with aura Albuminuria Biliary adenoma Osteonecrosis of jaw T-cell type acute leukaemia Arterial stiffness Stress urinary incontinence Brain abscess More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Dementia Alzheimer’s type

  • Study on Masupirdine for Treating Agitation in Alzheimer’s Dementia Patients

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Masupirdine
    Croatia Poland

  • Study of Lecanemab (BAN2401) Treatment in People with Early Alzheimer’s Disease: Testing Safety and Effectiveness Over 18 Months

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Prodromal Alzheimer’s disease
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Lecanemab
    France Germany Italy Spain Sweden

  • Study on the Effects of Semaglutide on Inflammation in Patients with Alzheimer’s Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Semaglutide
    Denmark Sweden

  • Study on the Long-term Safety and Effects of AL002 and Florquinitau F18 in Patients with Alzheimer’s Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Human Igg1 Monoclonal Antibody Against Trem2
    • Florquinitau (18F)
    France Germany Italy The Netherlands Poland Spain

  • Study on the Effects of JNJ-63733657 and Florquinitau F18 in Patients with Early Alzheimer’s Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • 6-(Fluoro-18F)-3-(1H-Pyrrolo[2,3-C]Pyridin-1-Yl)-5-Isoquinolinamine
    • Posdinemab
    Belgium France The Netherlands Spain Sweden

  • Study on Donanemab Dosing for Adults with Early Alzheimer’s Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Florbetaben (18F)
    • Donanemab
    • Sodium Chloride
    Italy
Previous Page
1 … 12 13 14 15
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!